Your session is about to expire
← Back to Search
Study Summary
This trial tests a new way to reduce wrinkles on the cheeks, by first making small holes in the skin and then using a machine to smooth them out. Up to 70 people will be treated twice to see how well it works.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your skin type is categorized as light to medium.I am using birth control and have a negative pregnancy test.I have a bleeding disorder or take medication that increases bleeding risk.I have non-cancerous skin conditions in the area that needs treatment.I am between 22 and 75 years old.Your skin type is fair to medium.The wrinkles on your cheeks are noticeable and scored at least a 3 on the Lemperle Wrinkle Scale by the person in charge of the study.You are currently smoking or have quit smoking within the past 3 months.I have a scar in the area that needs treatment.I have not had skin cancer or any related condition in the past 6 months.You are allergic or have a strong reaction to painkillers, Betadine, tumescent, Tegaderm, or tensioning tape that will be used in the study.I haven't had cosmetic skin treatments like fillers or Botox in the last 6 months.You have a history of developing raised, thick scars called keloids or hypertrophic scars.I have a condition that weakens my immune system or healing ability.I am between 22 and 75 years old.I have had an active or recurrent herpes infection in the last 6 months.I am using birth control and have a negative pregnancy test.I have not used tanning beds, creams, or had excessive sun exposure in the last 30 days.You are able and willing to comply with the treatment/follow-up schedule and requirements.I don't have silicone, tattoos, or non-removable body jewelry in the treatment area.
- Group 1: Treatment Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment for this trial restricted to individuals 45 years or younger?
"Individuals who fall between the age of 22 and 75 are allowed to enroll in this trial."
How many participants have opted to join this research endeavor?
"To successfully complete this trial, 70 eligible patients must be enrolled. The sponsor of the study is Venus Concept and two participating sites are DeNova Research in Chicago, Illinois and Menter Dermatology Research Institute based out of Dallas, Texas."
What is the geographic scope of this clinical investigation?
"The medical trial is looking for participants from four different recruiting sites including DeNova Research (Chicago), Menter Dermatology Research Institute (Dallas), Dr. Brian Kinney's practice in Beverly Hills, and an assortment of additional healthcare facilities."
Is the recruitment process ongoing for this trial?
"Per information found on clinicaltrials.gov, this health study is currently looking to enroll patients. The initial posting date was March 22nd 2022 and the latest update came in May 26th 2022."
Do I meet the criteria to become a participant of this experiment?
"This clinical trial seeks 70 individuals with wrinkles in the age range of 22 to 75 years. To qualify, applicants must be either male or female, literate and willing to read and sign an informed consent form, women of childbearing potential should use contraception for 3 months before enrolment and have a negative urine pregnancy test at baseline. Additionally, they need to have Fitzpatrick skin type I - IV as determined by the investigator using Lemperle Wrinkle Scale (score ≥3). Lastly, participants are expected to follow treatment/follow-up instructions throughout the study period."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Most responsive sites:
- DeNova Research: < 24 hours
Average response time
- < 1 Day
Typically responds via
Share this study with friends
Copy Link
Messenger